Related Experiment Video
Updated: Sep 19, 2025
04:00
A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells
Published on: September 7, 2011
66.5K
Vascular mimicry developments in non-small cell lung cancer
Xiaoyou Zhong1, Yiteng Gao1, Jiajia Lv1
1Department of Hematology and Oncology, Geriatric Hospital of Nanjing Medical University, Nanjing, 210024, China.
Biochemical and Biophysical Research Communications
|June 15, 2025
Summary
Vasculogenic mimicry (VM) in non-small cell lung cancer (NSCLC) allows tumor cells to form vascular channels, causing resistance to antiangiogenic therapies. Understanding VM is crucial for developing new NSCLC treatments.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related death globally.
- Conventional antiangiogenic therapies often show limited efficacy in NSCLC.
- Vasculogenic mimicry (VM), a process where tumor cells form vascular-like channels, contributes to therapeutic resistance.
Purpose of the Study:
- To investigate the mechanisms of VM formation in NSCLC.
- To explore the regulatory pathways involved in VM.
- To determine the association between VM and prognosis in NSCLC patients.
Main Methods:
- Detailed analysis of VM formation in NSCLC models.
- Identification of key molecular pathways regulating VM.
- Correlation studies between VM presence and patient outcomes.
Main Results:
- Tumor cells, not endothelial cells, form VM channels in NSCLC.
- VM structures provide nutrients and oxygen, promoting tumor progression.
- VM formation is linked to resistance against vascular endothelial growth factor (VEGF) targeted therapies.
Conclusions:
- VM is a significant factor in NSCLC therapeutic resistance.
- Targeting VM pathways may offer novel treatment strategies for NSCLC.
- Further research into VM mechanisms is vital for improving patient survival in NSCLC.
